Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
Number | Exp. Date | Activity Code(s) | Title |
---|---|---|---|
RFA-MH-25-115 | March 2, 2024 | U24 | BRAIN Initiative: Marmoset Colonies for Neuroscience Research (U24 Clinical Trials Not Allowed) |
RFA-MH-25-116 | March 2, 2024 | U24 | BRAIN Initiative: Marmoset Coordination Center (U24 Clinical Trials Not Allowed) |
RFA-DA-24-042 | February 16, 2024 | R34 | BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Optional) |
PA-23-317 | November 24, 2026 | 332 | Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) |
NOT-DC-24-010 | November 6, 2026 | R01 | Notice of Special Interest (NOSI): Tackling Acquisition of Language in Kids (TALK) R01 Research Projects |
NOT-HD-23-037 | January 1, 2026 | Notice of NICHD Withdrawal from Participation in NOT-HL-23-117 "Notice of Special Interest (NOSI): Palliative Care in the Care Continuum among Persons with Serious Heart, Lung, Blood and Sleep (HLBS) Diseases and their Caregivers" | |
PAR-24-073 | March 16, 2024 | K18 | Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Required) |
PAR-24-070 | March 16, 2024 | K18 | Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Not Allowed} |
NOT-OD-24-026 | July 16, 2024 | R21 | Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21) |
NOT-MH-24-125 | January 1, 2026 | Request for Information (RFI): BRAIN Initiative: Brain Behavior Quantification and Synchronization: Guidance for Opportunities in Development of Sensor Technology Hubs | |
NOT-NS-24-017 | January 1, 2026 | Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) | |
NOT-HD-23-034 | January 1, 2026 | Notice of Technical Assistance Webinar and FAQs for RFA-HD-24-007 (Understanding and Mitigating Health Disparities experienced by People with Disabilities caused by Ableism (R01 Clinical Trial Optional)) | |
PAR-24-043 | August 19, 2026 | UG3/UH3 | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
RFA-HD-25-008 | March 30, 2024 | R61/R33 | Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed) |
RFA-NS-24-028 | January 30, 2024 | U24 | BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed) |
NOT-AA-23-020 | November 30, 2026 | 333 | Notice of Special Interest (NOSI): Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-23-189 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
PAR-24-063 | August 19, 2026 | U44 | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
RFA-NS-24-019 | January 8, 2027 | UG3/UH3 | HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) |
PAR-23-293 | November 19, 2026 | R01 | Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) |
PAR-23-294 | November 19, 2026 | R21 | Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) |